Related Experiment Video

Updated: Dec 6, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.6K

Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Anton Camaj1, Michael S Miller1, Jonathan L Halperin1

  • 1The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.

Cardiology Clinics
|October 10, 2020
PubMed

Insights

Dual antithrombotic therapy, combining oral anticoagulation and a P2Y12-receptor inhibitor, is recommended for atrial fibrillation patients undergoing percutaneous coronary intervention. This strategy lowers bleeding risk without compromising ischemic event protection.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) often require combined oral anticoagulation (OAC) and antiplatelet therapies.
  • Triple antithrombotic therapy (OAC, P2Y12-receptor inhibitor, aspirin) has been the standard approach.
  • Emerging evidence suggests potential risks associated with triple therapy.

Purpose of the Study:

  • To review current advancements in antithrombotic strategies for atrial fibrillation patients post-PCI.
  • To analyze European and North American guidelines on dual versus triple antithrombotic therapy.
  • To guide clinical decision-making regarding optimal antithrombotic regimens.

Main Methods:

  • Review of randomized controlled trials comparing different antithrombotic strategies.
  • Analysis of current international guidelines and consensus documents.
  • Synthesis of evidence on efficacy and safety profiles of dual and triple therapies.

Main Results:

  • Dual antithrombotic therapy (OAC plus a P2Y12-receptor inhibitor) demonstrates reduced bleeding risk compared to triple therapy.
  • Randomized trials show no increase in ischemic events with dual therapy.
  • Guidelines increasingly favor de-escalation from triple to dual therapy.

Conclusions:

  • Dual antithrombotic therapy is a safer alternative to triple therapy for most atrial fibrillation patients undergoing PCI.
  • Clinical decisions should be informed by patient-specific risk factors and current evidence-based guidelines.
  • Further research may refine optimal duration and selection of agents in dual therapy regimens.

Keywords:
Atrial fibrillationDual antithrombotic therapyPercutaneous coronary interventionTriple antithrombotic therapy

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.7K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
170
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
131
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
153
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
148
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
143
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K